| Product Code: ETC9949439 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) NGS Services Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) NGS Services Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) NGS Services Market - Industry Life Cycle |
3.4 United Kingdom (UK) NGS Services Market - Porter's Five Forces |
3.5 United Kingdom (UK) NGS Services Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 United Kingdom (UK) NGS Services Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United Kingdom (UK) NGS Services Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.8 United Kingdom (UK) NGS Services Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) NGS Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision healthcare |
4.2.2 Technological advancements leading to reduced sequencing costs |
4.2.3 Growing applications of Next-Generation Sequencing (NGS) in research and diagnostics |
4.3 Market Restraints |
4.3.1 Data security and privacy concerns hindering adoption |
4.3.2 Lack of standardization in NGS data analysis and interpretation |
4.3.3 Regulatory challenges and compliance requirements impacting market growth |
5 United Kingdom (UK) NGS Services Market Trends |
6 United Kingdom (UK) NGS Services Market, By Types |
6.1 United Kingdom (UK) NGS Services Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) NGS Services Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 United Kingdom (UK) NGS Services Market Revenues & Volume, By SBS, 2021- 2031F |
6.1.4 United Kingdom (UK) NGS Services Market Revenues & Volume, By Ion Semiconductor, 2021- 2031F |
6.1.5 United Kingdom (UK) NGS Services Market Revenues & Volume, By SBL, 2021- 2031F |
6.1.6 United Kingdom (UK) NGS Services Market Revenues & Volume, By Pyro-Sequencing, 2021- 2031F |
6.1.7 United Kingdom (UK) NGS Services Market Revenues & Volume, By SMRT, 2021- 2031F |
6.2 United Kingdom (UK) NGS Services Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) NGS Services Market Revenues & Volume, By Research applications, 2021- 2031F |
6.2.3 United Kingdom (UK) NGS Services Market Revenues & Volume, By Clinical applications, 2021- 2031F |
6.2.4 United Kingdom (UK) NGS Services Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.2.5 United Kingdom (UK) NGS Services Market Revenues & Volume, By RNA-sequencing, 2021- 2031F |
6.2.6 United Kingdom (UK) NGS Services Market Revenues & Volume, By Targeted sequencing, 2021- 2031F |
6.2.7 United Kingdom (UK) NGS Services Market Revenues & Volume, By Exome sequencing, 2021- 2031F |
6.2.8 United Kingdom (UK) NGS Services Market Revenues & Volume, By Other, 2021- 2031F |
6.2.9 United Kingdom (UK) NGS Services Market Revenues & Volume, By Other, 2021- 2031F |
6.3 United Kingdom (UK) NGS Services Market, By Disease Type |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) NGS Services Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.3 United Kingdom (UK) NGS Services Market Revenues & Volume, By Lung cancer, 2021- 2031F |
6.3.4 United Kingdom (UK) NGS Services Market Revenues & Volume, By Breast cancer, 2021- 2031F |
6.3.5 United Kingdom (UK) NGS Services Market Revenues & Volume, By Prostate cancer, 2021- 2031F |
6.3.6 United Kingdom (UK) NGS Services Market Revenues & Volume, By Colorectal cancer, 2021- 2031F |
6.3.7 United Kingdom (UK) NGS Services Market Revenues & Volume, By Other, 2021- 2031F |
6.4 United Kingdom (UK) NGS Services Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) NGS Services Market Revenues & Volume, By Research centres, academic & government institutes, 2021- 2031F |
6.4.3 United Kingdom (UK) NGS Services Market Revenues & Volume, By Hospitals & clinics, 2021- 2031F |
6.4.4 United Kingdom (UK) NGS Services Market Revenues & Volume, By Pharmaceutical & biotechnology companies, 2021- 2031F |
6.4.5 United Kingdom (UK) NGS Services Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) NGS Services Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) NGS Services Market Export to Major Countries |
7.2 United Kingdom (UK) NGS Services Market Imports from Major Countries |
8 United Kingdom (UK) NGS Services Market Key Performance Indicators |
8.1 Average cost per genome sequenced |
8.2 Adoption rate of NGS in clinical diagnostics |
8.3 Number of research publications utilizing NGS technology |
8.4 Rate of investment in NGS technology by healthcare institutions |
8.5 Number of partnerships and collaborations in the UK NGS services market |
9 United Kingdom (UK) NGS Services Market - Opportunity Assessment |
9.1 United Kingdom (UK) NGS Services Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 United Kingdom (UK) NGS Services Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United Kingdom (UK) NGS Services Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.4 United Kingdom (UK) NGS Services Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) NGS Services Market - Competitive Landscape |
10.1 United Kingdom (UK) NGS Services Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) NGS Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here